Biomedical Engineering Reference
In-Depth Information
97. Oertel R, Richter K, Ebert U, Kirch W (2001) Determination of scopolamine in human
serum and microdialysis samples by liquid chromatography-tandem mass spectrometry.
J Chromatogr B 750:121-128
98. Stetina PM, Madai B, Kulemann V, Kirch W, Joukhadar C (2005) Pharmacokinetics of
scopolamine in serum and subcutaneous adipose tissue in healthy volunteers. Int J Clin
Pharmacol Ther 43:134-139
99. Oertel R, Richter K, Fauler J, Kirch W (2002) Increasing sample throughput in pharmaco-
logical studies by using dual-column liquid chromatography with tandem mass spectrometry.
J Chromatogr A 948:187-192
100. Boppana V, Miller-Stein C, Schaefer WH (1996) Direct plasma liquid chromatographic-tandem
mass spectrometric analysis of granisetron and its 7-hydroxy metabolite utilizing internal
surface reversed-phase guard columns and automated column switching devices. J Chromatogr
B 678:227-236
101. Machtejevas E, John H, Wagner K, Ständker L, Marko-Varga G, Forssmann WG, Bischoff R,
Unger KK (2004) Automated multi-dimensional liquid chromatography: sample preparation
and identification of peptides from human blood filtrate. J Chromatogr B 803:121-130
102. John H, Huynh KD, Hedtmann C, Walden M, Schulz A, Anspach FB, Forssmann WG (2005)
In vitro degradation of the antimicrobial human peptide HEM-g 130-146 in plasma analyzed
by a validated quantitative LC-MS/MS procedure. Anal Biochem 341:173-186
103. John H, Walden M, Schäfer S, Genz S, Forssmann WG (2004) Analytical procedures for
peptide quantification in pharmaceutical research by liquid chromatography-mass spectrom-
etry. Anal Bioanal Chem 378:883-897
104. John H, Worek F, Thiermann H (2008) LC-MS based procedures for monitoring of toxic
organophosphorus compounds and the verification of pesticide and nerve agent poisoning.
Anal Bioanal Chem 391:97-116
105. John H, Preissner KT, Forssmann WG, Ständker L (1999) Novel glycosylated forms of
human plasma endostatin and endostatin-related fragments of collagen XV. Biochemistry
38:10217-10224
106. John H, Forssmann WG (2001) Determination of the disulfide bond pattern of the endoge-
nous and recombinant angiogenesis inhibitor endostatin by mass spectrometry. Rapid
Commun Mass Spectrom 15:1222-1228
107. Thevis M, Vollmer DA (2012) Recent instrumental progress in mass spectrometry: advancing
resolution, accuracy and speed of drug detection 4:242-245
108. Würtinger P, Oberacher H (2012) Evaluation of the performance of a tandem mass spectral
library with mass spectral data extracted from literature 4:235-241
109. Sauvage FL, Saint-Marcoux F, Duretz B, Deporte D, Lachatre G, Marquet P (2006) Screening
of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spec-
trometry. Clin Chem 52:1735-1742
110. Gray TR, Shakleya DM, Huestis MA (2009) A liquid chromatography tandem mass spec-
trometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in
human meconium. Anal Bioanal Chem 393:1977-1990
111. Kjaergaard Bjork M, Nielsen MKK, Markussen LO, Klinke HB, Linnet K (2010)
Determination of 19 drugs of abuse and metabolites in whole blood by high-performance
liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 396:2393-2401
112. Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int
165:216-224
113. Drummer OH (2007) Requirements for bioanalytical procedures in post-mortem toxicology.
Anal Bioanal Chem 388:1495-1503
114. Schroff CD (1852) Über belladonna, atropin und daturin. Z KK Gesell Arzte Wien
3:211-242
115. Van Zutphen LFM (1974) Serum esterase genetics in rabbits. I. Phenotypic variation of the
prealbumin esterases and classification of atropinesterase and cocainesterase. Biochem
Genetics 12:309-326
